Buy BROMADOLINE (U-47931E) – 99,8% PURITY.

BROMADOLINE (U-47931E) has a potency lying between that of codeine and morphine, being slightly stronger than pentazocine. Bromadoline is related to AH-7921 and U-47700.

BROMADOLINE (U-47931E) is an Opioid Analgesic selective for the μ-opioid receptor developed by the Upjohn company in the 1970s. The drug has a potency lying between that of codeine and morphine, being slightly stronger than Pentazocine.

This chemical is intended for research and forensic applications.

The side effects of Bromadoline have not been studied.

The complete chemical formula is: trans-3,4-dichloro-N-(2-(dimethylamino)cyclohexyl)-N-methylbenzamide.

Storage conditions: in a dry and cool place. The term  can last up to 2 years under the right storage conditions.

Side effects of BROMADOLINE

Side effects of this drug (U-47931E) may include itchiness, sedation, nausea, respiratory depression, constipation, and euphoria. Long-term use can cause tolerance, meaning that increased doses are required to achieve the same effect, and physical dependence, meaning that abruptly discontinuing the drug leads to unpleasant withdrawal symptoms. The euphoria attracts recreational use, and frequent, escalating recreational use of opioids typically results in addiction. An overdose or concurrent use with other depressant drugs like benzodiazepines commonly results in death from respiratory depression.

This drug (U-47931E) acts by binding to opioid receptors, which are found principally in the central and peripheral nervous system and the gastrointestinal tract. These receptors mediate both the psychoactive and the somatic effects of opioids. Opioid drugs include partial agonists, like the anti-diarrhoea drug loperamide and antagonists like naloxegol for opioid-induced constipation, which do not cross the blood-brain barrier but can displace other opioids from binding to those receptors.